About the Event
The 2nd Structure-Based Drug Design Summit San Diego is the leading West Coast meeting dedicated exclusively to advancing structure-based drug design, bringing together structural biologists, computational chemists, medicinal chemists, and drug discovery leaders to share practical strategies, tools, and case studies.
This summit is designed for structural biologists, computational chemists, medicinal chemists, biophysicists, protein scientists, AI/ML specialists, and drug discovery professionals working to accelerate the development of novel therapeutics through structural insights.
Unlike broader drug discovery meetings, this summit is the only structural biology conference spanning the full toolbox, across Cryo-EM, cryo-ET, X-ray crystallography, NMR and AI covered in one integrated program, versus other conferences focusing on a single technology.
Our content agenda is also built around application in drug discovery, with case study led sessions on how structures drive design decisions, not just how to determine them.
This is also an independent meeting that gives biopharma and vendors a level playing field.
Program & Content
Sessions will explore AI-driven structure prediction, de novo design, cryo-EM, X-ray crystallography, NMR, protein dynamics, membrane proteins, GPCRs, molecular glues, protein degraders, biologics, and other emerging modalities.
Yes. The agenda includes dedicated discussions and workshops on integrating AI and machine learning into structure-based drug design workflows and translating these tools into practical discovery applications
Yes. Attendees can participate in deep-dive pre-conference workshops focused on integrating structural biology techniques and applying AI and machine learning to drug design.
Networking
The summit includes speed networking, interactive roundtables, panel discussions, poster sessions, networking receptions, and dedicated discussion periods designed to facilitate meaningful connections with peers and industry leaders.
You'll connect with structural biology and drug discovery professionals from leading pharmaceutical and biotechnology companies, including organizations such as Gilead, Vertex, Sanofi, Eli Lilly, Novartis, Pfizer, Amgen, and many others.
Registration
Registration provides access to the conference sessions, keynote presentations, case studies, panel discussions, networking opportunities, and other activities included within your chosen pass type. Additional workshop access may depend on your registration package.
Absolutely. The summit is designed for cross-functional collaboration and attracts professionals across structural biology, computational chemistry, medicinal chemistry, protein sciences, and broader drug discovery teams.
In fact, if you register with 3+ more colleagues you will be able to save up to 20% on your conference pass. Contact the team today about group bookings
Sponsorship
Sponsorship provides an opportunity to showcase technologies, platforms, and services directly to structural biologists, computational chemists, and drug discovery leaders actively seeking innovative solutions to accelerate discovery and development.
The event attracts companies offering AI-enabled drug discovery tools, structural biology platforms, cryo-EM solutions, computational chemistry software, CRO services, and other technologies supporting structure-based drug design workflows.
Venue & Logistics
The summit will be held at the Westgate Hotel in San Diego, California, from February 2-4, 2027.
Explore the Agenda
Discover the latest strategies to integrate AI-enabled structure prediction, de novo design, and experimental validation for structure-based drug design through expert-led case studies, technical deep dives, panel discussions, and interactive workshops.
Partner With Us
Showcase your technologies, platforms, and services to structural biologists, computational chemists, and drug discovery leaders actively tackling structural bottlenecks and seeking partners to accelerate discovery, validation, and candidate progression.
Join Structure-Based Drug Design Leaders
Connect with structural biologists, computational and medicinal chemists, and drug discovery experts driving the next generation of structure-enabled discovery through innovation in target characterization, molecule design, and structural validation.